Table 1 Probability of specific high-risk (HR) human papillomavirus (HPV) types persistence at 18 months after baseline among Tanzanian women-overall and according to HIV status
HPV type at enrollment | n/Na | Probability of persistence of specific HR HPV types at 18 months after baseline | |||||
|---|---|---|---|---|---|---|---|
Overall | According to HIV status | ||||||
Probability | (95% CI) | HIV positive | HIV negative | ||||
Probability | (95% CI) | Probability | (95% CI) | ||||
HPV 16 | 31/89 | 34.8 | (19.9–60.9) | 55.6 | (31.0–99.7) | 30.4 | (16.4–56.5) |
HPV 18 | 14/67 | 25.0 | (7.5–83.0) | 41.7 | (21.4–81.4) | 22.7 | (10.5–49.1) |
HPV 31 | 20/54 | 30.0 | (11.6–77.3) | 33.3 | (6.7–100.0) | 33.3 | (10.8–100.0) |
HPV 33 | 11/29 | 16.7 | (2.8–99.7) | 0 | 20.0 | (3.5–100.0) | |
HPV 35 | 19/66 | 37.5 | (22.4–62.9) | 33.3 | (6.7–100.0) | 33.3 | (16.3–68.2) |
HPV 39 | 4/26 | 0 | 0 | 0 | |||
HPV 45 | 8/39 | 0 | 57.1 | (30.1–100.0) | 0 | ||
HPV 51 | 9/57 | 18.2 | (7.5–44.1) | 14.3 | (2.3–87.7) | 18.5 | (8.4–40.9) |
HPV 52 | 37/105 | 29.6 | (16.6–53.0) | 33.3 | (15.0–74.2) | 33.3 | (15.0–74.2) |
HPV 56 | 8/34 | 26.7 | (11.5–61.7) | 40.0 | (21.5–74.3) | 15.4 | (4.3–55.0) |
HPV 58 | 23/70 | 50.0 | (36.1–69.3) | 50.0 | (30.6–81.6) | 37.5 | (19.9–70.6) |
HPV 59 | 3/21 | 12.5 | (2.0–78.2) | 0 | 20.0 | (5.8–69.1) | |
HPV 68 | 11/50 | 26.9 | (14.3–50.7) | 33.3 | (15.0–74.2) | 33.3 | (10.8–100.0) |